Cargando…
Ppm1b Negatively Regulates 3-Bromopyruvate Induced Necroptosis in Breast Cancer Cells
Up to 30% of breast cancer mortality is caused by cancer relapse despite primary clinical treatments due to distant metastases. Further research focusing on breast cancer mechanisms are needed for deeper understanding of disease prognosis. 3-bromopyruvate (3-BP), a glycolysis inhibitor, has been stu...
Autores principales: | Sun, Yiming, Pan, Qiong, Ma, Linyan, Chen, Chao, Zhao, Surong, Liu, Hao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7841011/ https://www.ncbi.nlm.nih.gov/pubmed/33520691 http://dx.doi.org/10.3389/fonc.2020.555546 |
Ejemplares similares
-
Retraction: Ppm1b Negatively Regulates 3-Bromopyruvic Acid Induced Necroptosis in Breast Cancer Cells
Publicado: (2021) -
Mechanisms underlying 3-bromopyruvate-induced cell death in colon cancer
por: Sun, Yiming, et al.
Publicado: (2015) -
3-Bromopyruvate sensitizes human breast cancer cells to TRAIL-induced apoptosis via the phosphorylated AMPK-mediated upregulation of DR5
por: Chen, Yuzhong, et al.
Publicado: (2018) -
3-Bromopyruvate sensitizes human breast cancer cells to TRAIL-induced apoptosis via the phosphorylated AMPK-mediated upregulation of DR5
por: Chen, Yuzhong, et al.
Publicado: (2022) -
LncRNA PPM1A-AS Regulate Tumor Development Through Multiple Signal Pathways in T-Cell Acute Lymphoblastic Leukemia
por: Li, Guoli, et al.
Publicado: (2021)